Bringing CAR T cell therapy trials to underserved populations.
Cancer Cell
; 41(12): 2007-2010, 2023 12 11.
Article
en En
| MEDLINE
| ID: mdl-37890490
ABSTRACT
There is a critical need for equitable access to cell therapies in cancer treatment, particularly within public safety-net healthcare systems that serve minority and socioeconomically disadvantaged populations. We discuss how the Dan L Duncan Comprehensive Cancer Center at Baylor College of Medicine is piloting a cell therapy program aimed at addressing cancer care disparities and has the potential to serve as a national model for enhancing health equity in cancer care.
Texto completo:
1
Base de datos:
MEDLINE
Asunto principal:
Inmunoterapia Adoptiva
/
Poblaciones Vulnerables
Idioma:
En
Revista:
Cancer Cell
Asunto de la revista:
NEOPLASIAS
Año:
2023
Tipo del documento:
Article